Geisinger Medical Center, Department of Gastroenterology and Hepatology, Danville, PA 17822, USA.
Department of Biochemistry and Molecular Biology, The Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Nutrients. 2021 Jan 26;13(2):370. doi: 10.3390/nu13020370.
Hepatic encephalopathy (HE) is a common neurological consequence in patients with cirrhosis and has a healthcare burden of USD 5370 to 50,120 per patient annually. HE significantly hampers the quality of life and is a major cause of morbidity and mortality. Patients with cirrhosis are at a high risk for protein-calorie malnutrition due to altered metabolism. Current evidence has changed the old belief of protein restriction in patients with cirrhosis and now 1.2 to 1.5 g/kg/day protein intake is recommended. Case series and studies with small numbers of participants showed that a vegetarian protein diet decreases the symptoms of HE when compared to a meat-based diet, but the evidence is limited and requires further larger randomized controlled trials. However, vegetable or milk-based protein diets are good substitutes for patients averse to meat intake. Branch chain amino acids (BCAA) (leucine, isoleucine and valine) have also been shown to be effective in alleviating symptoms of HE and are recommended as an alternative therapy in patients with cirrhosis for the treatment of HE. In this review, we provide an overview of current literature evaluating the role of protein intake in the management of HE in cirrhosis.
肝性脑病(HE)是肝硬化患者常见的神经学后果,每年每位患者的医疗负担为 5370 至 50120 美元。HE 严重影响生活质量,是发病率和死亡率的主要原因。由于代谢改变,肝硬化患者存在蛋白质-热量营养不良的高风险。目前的证据改变了肝硬化患者蛋白质限制的旧观念,现在建议每天摄入 1.2 至 1.5 克/公斤蛋白质。病例系列和少数参与者的研究表明,与基于肉类的饮食相比,素食蛋白质饮食可降低 HE 的症状,但证据有限,需要进一步进行更大规模的随机对照试验。然而,植物性或牛奶蛋白饮食是那些不喜欢摄入肉类的患者的良好替代品。支链氨基酸(BCAA)(亮氨酸、异亮氨酸和缬氨酸)也已被证明可有效缓解 HE 症状,被推荐作为肝硬化患者治疗 HE 的替代疗法。在这篇综述中,我们概述了评估肝硬化患者 HE 管理中蛋白质摄入作用的现有文献。